—

GALDERMA GROUP AG(GALDY)— 同業公司組

數據截至2026-10-14 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

GALDERMA GROUP AG的Closelook綜合評分為55/100,在同業公司組內排名第8位(共11家)——組內評分最高的是Halozyme Therapeutics Inc(74/100)。

名稱綜合動能品質估值訊號距52週高點
GALDY GALDERMA GROUP AG55525825info11.4%
ROVI.MC Laboratorios Farmaceuticos ROVI61297749info30.7%
LNTH Lantheus Holdings Inc60697353info10.6%
KNSA Kiniksa Pharmaceuticals Ltd56945718ok4.9%
BHC.TO Bausch Health Companies Inc55657082info24.2%
FAGR.BR Fagron NV53435559info11.1%
ALKS Alkermes Plc51495122info29.8%
HALO Halozyme Therapeutics Inc74979447ok2%
DXCM DexCom Inc65818034bull8.1%
ARGX argenx NV ADR61507427info23.7%
HQY HealthEquity Inc61566942info16.5%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-14

Quick answers

GALDERMA GROUP AG在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Bausch Health Companies Inc (BHC.TO)、Fagron NV (FAGR.BR)、Alkermes Plc (ALKS)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

GALDY相對同業公司的評分如何?

GALDERMA GROUP AG的綜合評分為55/100,組內排名第8位(共11家),截至2026-10-14;組內最高綜合評分為Halozyme Therapeutics Inc(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.